These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 15761515)
1. [Evaluation of LDL susceptibility of patients with type 1 diabetes to in vitro oxidation and its relation to glycemic control]. Castro SH; Castro-Faria-Neto HC; Clemente EL; Gomes MB Arq Bras Endocrinol Metabol; 2004 Aug; 48(4):513-7. PubMed ID: 15761515 [TBL] [Abstract][Full Text] [Related]
2. Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1. Liguori A; Abete P; Hayden JM; Cacciatore F; Rengo F; Ambrosio G; Bonaduce D; Condorelli M; Reaven PD; Napoli C Eur Heart J; 2001 Nov; 22(22):2075-84. PubMed ID: 11686665 [TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor acetylhydrolase (PAF-AH) activity in patients with type 1 diabetes mellitus. de Castro SH; Faria Neto HC; Gomes MB Arq Bras Cardiol; 2007 Feb; 88(2):179-84. PubMed ID: 17384835 [TBL] [Abstract][Full Text] [Related]
4. Absence of increased susceptibility of LDL to oxidation in type 1 diabetics. O'Brien SF; Mori TA; Puddey IB; Stanton KG Diabetes Res Clin Pract; 1995 Dec; 30(3):195-203. PubMed ID: 8861459 [TBL] [Abstract][Full Text] [Related]
5. [QTc interval and traditional risk factors to atherosclerotic disease in patients with type 1 diabetes]. Castro SH; Faria-Neto HC; Gomes MB Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1153-9. PubMed ID: 18157392 [TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein (LDL) behavior after in vitro oxidation in three groups of diabetics. Seghrouchni I; Drai J; Bannier E; Garcia I; Revol A Farmaco; 2001; 56(5-7):471-4. PubMed ID: 11482781 [TBL] [Abstract][Full Text] [Related]
7. Impact of concentrations of glycated hemoglobin, alpha-tocopherol, copper, and manganese on oxidation of low-density lipoproteins in patients with type I diabetes, type II diabetes and control subjects. Leonhardt W; Hanefeld M; Müller G; Hora C; Meissner D; Lattke P; Paetzold A; Jaross W; Schroeder HE Clin Chim Acta; 1996 Oct; 254(2):173-86. PubMed ID: 8896905 [TBL] [Abstract][Full Text] [Related]
8. LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation. Jenkins AJ; Klein RL; Chassereau CN; Hermayer KL; Lopes-Virella MF Diabetes; 1996 Jun; 45(6):762-7. PubMed ID: 8635650 [TBL] [Abstract][Full Text] [Related]
9. Lower susceptibility of low density lipoprotein to in vitro oxidation in diabetic patients. Taus M; Ferretti G; Curatola G; Dousset N; Solèra ML; Valdiguie P Biochem Int; 1992 Dec; 28(5):835-42. PubMed ID: 1288493 [TBL] [Abstract][Full Text] [Related]
10. Hyperketonemia (acetoacetate) increases the oxidizability of LDL + VLDL in Type-I diabetic patients. Jain SK; McVie R; Jaramillo JJ; Chen Y Free Radic Biol Med; 1998 Jan; 24(1):175-81. PubMed ID: 9436628 [TBL] [Abstract][Full Text] [Related]
11. LDL oxidation is associated with increased blood hemoglobin A1c levels in diabetic patients. Hussein OA; Gefen Y; Zidan JM; Karochero EY; Luder AS; Assy NN; Sror ES; Aviram MY Clin Chim Acta; 2007 Feb; 377(1-2):114-8. PubMed ID: 17070510 [TBL] [Abstract][Full Text] [Related]
12. Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation. Boemi M; Leviev I; Sirolla C; Pieri C; Marra M; James RW Atherosclerosis; 2001 Mar; 155(1):229-35. PubMed ID: 11223446 [TBL] [Abstract][Full Text] [Related]
13. Susceptibility to oxidation and physicochemical properties of LDL in insulin-dependent diabetics. Feillet C; Roche B; Tauveron I; Bayle D; Rock E; Borel P; Rayssiguier Y; Thiéblot P; Mazur A Atherosclerosis; 1998 Feb; 136(2):405-7. PubMed ID: 9543114 [No Abstract] [Full Text] [Related]
14. Do E-series prostaglandins and their metabolites influence oxidation of native and glycated low-density lipoproteins? Sobal G; Menzel JE; Sinzinger H Prostaglandins Other Lipid Mediat; 1998 Jan; 55(1):67-76. PubMed ID: 9661219 [TBL] [Abstract][Full Text] [Related]
15. Association of postprandial hyperglycemia with in vitro LDL oxidation in non-smoking patients with type 1 diabetes--a cross-sectional study. de Castro SH; Castro-Faria-Neto HC; Gomes MB Rev Diabet Stud; 2005; 2(3):157-64. PubMed ID: 17491690 [TBL] [Abstract][Full Text] [Related]
16. Type 1 diabetes and ageing: does LDL oxidation mediate their associations with coronary heart disease? Valabhji J; Elkeles RS Eur Heart J; 2001 Nov; 22(22):2045-7. PubMed ID: 11686659 [No Abstract] [Full Text] [Related]
17. Glycation accelerates the oxidation of low density lipoprotein by copper ions. Kobayashi K; Watanabe J; Umeda F; Nawata H Endocr J; 1995 Aug; 42(4):461-5. PubMed ID: 8556051 [TBL] [Abstract][Full Text] [Related]
18. Endothelial dysfunction in Type 1 diabetes mellitus: relationship with LDL oxidation and the effects of vitamin E. Pinkney JH; Downs L; Hopton M; Mackness MI; Bolton CH Diabet Med; 1999 Dec; 16(12):993-9. PubMed ID: 10656227 [TBL] [Abstract][Full Text] [Related]
19. Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes. Mironova MA; Klein RL; Virella GT; Lopes-Virella MF Diabetes; 2000 Jun; 49(6):1033-41. PubMed ID: 10866057 [TBL] [Abstract][Full Text] [Related]
20. Glucose influence on copper ion-dependent oxidation of low density lipoprotein. Ghaffari MA; Mojab S Iran Biomed J; 2009 Jan; 13(1):59-64. PubMed ID: 19252679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]